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Hepatitis B virus (HBV) replication requires the viral polymerase to reverse transcribe the 3.5-kb pregenomic viral RNA within the
nucleocapsid. It has been proposed that a sequence element designated phi (ϕ), which is located 32 nucleotides upstream of the 3′ DR1
pregenomic RNA sequence and is complementary to ε, is required for efficient minus-strand synthesis because it may mediate the translocation of
the viral polymerase plus the three nucleotide primer from ε to DR1. A mutation in ϕ has been identified which can be compensated for with a
complementary mutation in ε. This observation supports the suggestion that ε and ϕ base pair during the process of polymerase translocation from
ε to DR1. However, additional mutations in ϕ were not complemented by the corresponding mutations in ε indicating that the functional
recognition of ε and ε/ϕ stem-loop structures by polymerase probably requires both sequence- and structure-specific information.
© 2006 Elsevier Inc. All rights reserved.Keywords: Hepatitis B virus; Replication; Epsilon; PhiIntroduction
The replication strategy of hepadnaviruses is unique for a
DNA virus (Ganem and Schneider, 2001). Although the viral
genome is a 3.2-kb partially double-stranded DNA molecule, it
is generated by the reverse transcription of a greater-than-
genome length 3.5-kb pregenomic RNA (Will et al., 1987;
McLachlan, 1991). The 3.5-kb pregenomic RNA is one of
several viral transcripts synthesized from nuclear HBV
covalently closed circular (CCC) DNA by the cellular RNA
polymerase (Cattaneo et al., 1984; Yokosuka et al., 1986;
Imazeki et al., 1987; Su et al., 1989; Russnak and Ganem,
1990). These nuclear genomes are derived from virions
infecting the hepatocytes or newly synthesized viral capsids
cycling viral genomic DNA back into the nucleus as part of the
HBV CCC DNA intracellular amplification pathway (Tuttle-
man et al., 1986; Raney and McLachlan, 1991).
The 3.5-kb pregenomic RNA is translated into the viral core
and polymerase polypeptides (Will et al., 1987; Ou et al., 1990).
The HBV polymerase recognizes and binds to a stem-loop⁎ Corresponding author. Fax: +1 312 996 4890.
E-mail addresses: coropeza@uic.edu (C.E. Oropeza), mclach@uic.edu
(A. McLachlan).
0042-6822/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2006.08.036structure called epsilon (ε) located at the 5′-end of the 3.5-kb
pregenomic RNA (Junker-Niepmann et al., 1990; Knaus and
Nassal, 1993; Pollack and Ganem, 1994; Wang et al., 1994).
This ribonucleoprotein complex is subsequently encapsidated
by the core polypeptide generating an immature capsid (Hirsch
et al., 1990; Bartenschlager et al., 1990; Bartenschlager and
Schaller, 1992; Pollack and Ganem, 1993; Pollack and Ganem,
1994; Fallows and Goff, 1995). Initially, the HBV polymerase
utilizes a tyrosine residue within its own amino-terminal
domain as a primer to synthesize three nucleotides using the
six nucleotide bulge region located in the stem of ε as a template
(Gerlich and Robinson, 1980; Wang and Seeger, 1992, 1993;
Zoulim and Seeger, 1994; Weber et al., 1994; Tavis et al., 1994;
Lanford et al., 1995, 1997; Nassal and Rieger, 1996; Jiang and
Loeb, 1997). The polymerase with the covalently attached
trinucleotide sequence subsequently translocates to the DR1
element located at the 3′-end of the 3.5-kb pregenomic RNA
(Seeger and Maragos, 1991; Tavis et al., 1994; Tavis and
Ganem, 1995; Loeb and Tian, 1995; Nassal and Rieger, 1996).
The mechanism governing this step in the replication cycle is
not completely defined, but a sequence called phi (ϕ) which is
complementary to the 5′-half of ε has been shown to influence
an early step in the viral replication cycle (Tang andMcLachlan,
2002a). Interestingly, the covalent attachment of the initial three
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conformational change in the pregenomic RNA plus polymer-
ase ribonucleoprotein complex (Tavis and Ganem, 1996; Tavis
et al., 1998; Beck and Nassal, 1998). This conformational
change may facilitate the exchange of the 3′-half of ε, which is
initially base paired with the 5′-half of ε, for the ϕ sequence
located 32 nucleotides upstream of the DR1 element at the
3′-end of the pregenomic RNA (Tang and McLachlan, 2002a).
This would bring the three nucleotides covalent attached to the
HBV polymerase in proximity to their complementary sequence
within the DR1 sequence. Association of these three nucleotides
with the DR1 element would permit elongation of HBV minus-
strand DNA by reverse transcription of the 3.5-kb pregenomic
RNA (Wang and Seeger, 1993). Elongation of minus-strand
DNA to the end of the pregenomic RNA generates the complete
HBV minus-strand DNA. As a result of the RNaseH activity
present in the carboxy-terminal domain of the HBV polymerase,
the pregenomic RNA is degraded generating an approximately
17 nucleotide primer derived from the 5′-end of the pregenomic
RNA (Lien et al., 1986; Will et al., 1987; Loeb et al., 1991). This
sequence includes the 5′-end copy of the DR1 sequence which is
translocated to the complementary DR2 sequence within the
newly synthesized HBV minus-strand DNA (Will et al., 1987;
Seeger et al., 1986; Staprans et al., 1991; Loeb et al., 1996;
Seeger and Maragos, 1989). This RNA primer serves to initiate
plus-strand DNA synthesis leading ultimately to the production
of the relaxed-circular 3.2-kb DNA present in the mature virions
(Will et al., 1987; Loeb et al., 1997; Lien et al., 1987; Havert and
Loeb, 1997).
In this study, the early steps in the viral replication cycle are
examined further and the importance of the complementarity
between ε and ϕ is evaluated. Extensive mutational analysis
within the ϕ sequence demonstrates the critical importance of
this sequence element in the early steps of viral replication.
Analysis of complementary mutations between ε andϕ indicates
that base pairing between these two sequence elements does
occur and is essential for efficient viral replication. Although
base pairing between ε and ϕ likely contributes to efficient viral
replication, it is apparent that there are also sequence specific
requirements within these regulatory elements that are essential
for efficient viral replication. Similar conclusions have recently
been reported by others (Abraham and Loeb, 2006). Finally, it is
apparent that the ϕ sequence element cannot substitute for the
3′-half of ε in the initiation of viral replication despite its
complementarity to the 5′-half of ε. This observation supports
the suggestion that polymerase recognizes the stem-loop
structure of ε and ε/ϕ in a functionally distinct manner.
Results
Effect of mutations in the ϕ sequence on the efficiency of HBV
replication
The ϕ sequence is located 32 nucleotides upstream of DR1
in the 3′-end of the pregenomic RNA (Fig. 1) and has been
shown to contribute to the efficiency of HBV replication in cell
culture (Tang and McLachlan, 2002a). In addition, it was notedthat the ϕ sequence is complementary to the 5′-half of the ε
sequence suggesting a model for the translocation of the HBV
polymerase from ε at the 5′-end of the pregenomic RNA to the
DR1 element at the 3′-end of the pregenomic RNA (Tang and
McLachlan, 2002a). In this model, the pregenomic RNA and
possibly the HBV polymerase would undergo a conformational
change after the first three nucleotides of the minus-strand are
synthesized (Beck and Nassal, 1998; Tang and McLachlan,
2002a; Tavis and Ganem, 1996; Tavis et al., 1998). During this
conformational change, the 3′-half of the ε sequence at the
5′-end of the pregenomic RNA would be exchanged for the ϕ
sequence at the 3′-end of the pregenomic RNA (Tang and
McLachlan, 2002a). This would presumably bring the three
nucleotide primer into proximity with DR1, allowing it to initiate
synthesis of theminus-strand DNA from this location (Wang and
Seeger, 1993).
The original mutagenesis analysis of the ϕ sequence was
performed using a wild-type HBV genome (Tang and McLa-
chlan, 2002a). As the ϕ sequence is located in the X-gene open
reading frame, the types of mutations that could be introduced
in the original study were limited to those which did not alter the
X-gene encoded polypeptide amino acid sequence (Tang and
McLachlan, 2002a). In this study, a comprehensive set of
mutations was introduced into the ϕ sequence (Fig. 1).
Consequently, all mutagenesis analysis performed in this
study used an HBV genome defective in X-gene polypeptide
expression due to the conversion of the translation initiation
codon from AUG to GUG. In addition, the HBV DNA (4.1 kbp)
XPC construct used to characterize both the ε and ϕ
mutations contained an additional mutation in the precore
initiation codon which was also mutated to GUG to prevent the
expression of the precore polypeptide (Tang and McLachlan,
2002b). As a result of these mutations, the HBV DNA (4.1 kbp)
XPC construct does not express either the X-gene or the
precore polypeptide. Therefore, it is possible to mutate both ε
and ϕ in this HBV genome without having to be concerned
about altering the expression of these two viral gene products.
Fortunately, it is apparent that the absence of the X-gene and
precore polypeptides has a limited effect on HBV transcription
and replication in HepG2 cells (Figs. 2–4).
In an initial attempt to further characterize the ϕ sequence
elements contributing to efficient viral replication, a series of six
nucleotide substitutions, M9ϕ, M10ϕ, M11ϕ, M12ϕ and
M13ϕ, were introduced into the region of the ϕ sequence
located at the 3′-end of the HBV DNA (4.1 kbp) XPC
construct and their effect on HBV RNA and DNA synthesis was
determined in HepG2 cells (Figs. 1 and 2). The pregenomic
RNA transcribed from these constructs was mutated only at the
3′-end of the transcript and the levels of the HBV transcripts
were not influenced by the mutations in the ϕ sequence (Fig. 2).
The level of replication per 3.5-kb viral transcript was not
affected by the M9ϕ mutation which was not located within the
ϕ sequence (Fig. 2). In contrast, the M10ϕ, M12ϕ and M13ϕ
mutations reduce the level of replication per 3.5-kb viral
transcript approximately two-fold, whereas the M11ϕ mutation
reduced the level of replication per 3.5-kb viral transcript
approximately four-fold (Fig. 2). These results are consistent
Fig. 1. Structure and sequence of the HBV constructs supporting viral transcription and replication in the human HepG2 hepatoma cell line. (A) Structure of the HBV
DNA (4.1 kbp) construct used in transient transfection analysis. The 4.1-kbp greater-than-genome lengthHBVDNA sequence in this construct spans coordinates 1072–
3182/1–1990 of the HBV genome (subtype ayw). The locations of the HBV 3.5-kb, 2.4-kb, 2.1-kb and 0.7-kb transcripts are indicated. EnhI/Xp, enhancer I/X-gene
promoter region; Cp, nucleocapsid or core promoter; pA, polyadenylation site; PS1p, presurface antigen promoter; Sp, major surface antigen promoter; X, X-gene;
S, surface antigen gene; C, core gene; P, polymerase gene; ORF, open reading frame. (B) Sequence of the HBV phi (ϕ), DR1 and epsilon (ε) region of the viral
genome. The M9ϕ to M17ϕ mutations spanning the ϕ region are indicated above the HBV nucleotide sequence. These mutations were only introduced into the
3′-end of the HBV DNA (4.1 kbp) construct. The M14ε, M15ε and Mεtoϕmutations spanning the ε sequence are also indicated above the HBV nucleotide sequence.
The sequence of the precore and X-gene translation initiation codons was mutated from ATG to GTG in the HBV DNA (4.1 kbp) XPC constructs to prevent the
expression of the precore and X-gene polypeptides from the HBV genomes containing ε andϕmutations. The location of the precore (PC) and pregenomic or core (C)
RNA initiation sites is indicated. Precore/core open reading frame, PC/C-ORF; X-gene open reading frame, X-ORF.
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performed using the wild-type HBV genome (Tang and
McLachlan, 2002a). In combination, they indicate that the
complete ϕ sequence plus as many as an additional six
nucleotides located upstream of the ϕ sequence (M10ϕ)
contribute to efficient HBV DNA synthesis and the central
region of this sequence appears to be the most sensitive to
nucleotide substitutions.Additional mutational analysis of the ϕ sequence was per-
formed in an attempt to find ϕ mutations that might permit the
analysis of complementary mutations in the ε sequence (Fig. 3).
For this analysis, a series of limited clustered point mutations,
M14ϕ, M15ϕ, M16ϕ and M17ϕ, were introduced into the
region of the ϕ sequence located at the 3′-end of the HBV DNA
(4.1 kbp) XPC construct and their effect of HBV RNA and
DNA synthesis was determined in HepG2 cells (Figs. 1 and 3).
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mutated only at the 3′-end of the transcript, and the levels of the
HBV transcripts were not influenced by these mutations in theϕ
sequence (Fig. 3B). The level of replication per 3.5-kb viral
transcript observed with the M14ϕ, M16ϕ andM17ϕmutationswas reduced less than two-fold, whereas the M15ϕ mutation
reduced replication per 3.5-kb viral transcript more than two-
fold (Fig. 3). These results are consistent with all the previous
mutational analysis of the ϕ sequence and support the
suggestion that the central region of the ϕ sequence is the
most sensitive to nucleotide substitutions. In addition, it appears
that the greater the region of disruption to the base pairing
between the 5′-half of ε and theϕ sequence, the greater the effect
on viral replication (Figs. 2 and 3) (Tang and McLachlan,
2002a).
Effects of compensatory mutations in the ε and ϕ sequences on
the efficiency of HBV replication
Since the M15ϕ mutation reduced replication to the greatest
extent (Fig. 3), the effect of introducing the corresponding
compensatory mutations into the 5′-half of ε was examined
(Fig. 4). The compensatory mutation, M15ε (Fig. 1), introduced
into the 5′-half of ε has been characterized previously and
shown to support encapsidation of pregenomic RNA at a level
two to three times lower than the wild-type RNA (Pollack and
Ganem, 1993). Consequently, it was assumed that the M15ε
mutant pregenomic RNAwould be encapsidated and potentially
support viral replication. The M15ε mutation introduced into
the ε sequence at the 5′-end of the pregenomic RNA (M15 5′ε)
reduced the level of viral replication per 3.5-kb viral transcript
approximately five-fold without affecting pregenomic RNA
synthesis (Fig. 4). The reduction in viral replication presumably
reflects contributions from either or both the reduced efficiency
of pregenomic RNA encapsidation and pregenomic RNA
rearrangement during the formation of the ε/ϕ structure. To
examine these possibilities, the level of replication supported by
the double M15 5′εϕ mutation was compared to the individual
mutations (Fig. 4). The double M15 5′εϕ mutation supported a
higher level of replication per 3.5-kb viral transcript than either
single mutation alone (M15 5′ε and M15ϕ), and the level ofFig. 2. Effect of mutations in the ϕ sequence on HBV transcription and
replication in HepG2 cells. (A) Structure of the putative HBV ε/ϕ stem–bulge
sequence (Tang and McLachlan, 2002a). The location of the HBV polymerase
with the three covalently attached nucleotides after translocation from ε to DR1 is
indicated. The locations of the M10ϕ to M13ϕmutations are also indicated. The
pregenomic RNA sequence is derived from the HBVayw genome (Galibert et al.,
1979). (B) RNA (Northern) filter hybridization analysis of HBV transcripts. Cells
were transiently transfected with the wild-type HBV DNA (4.1 kbp) construct
(lane 1) and the mutant HBV DNA (4.1 kbp) constructs X (lane 2), PC (lane
3), XPC (lane 4), M9ϕ (lane 5), M10ϕ (lane 6), M11ϕ (lane 7), M12ϕ (lane
8) and M13ϕ (lane 9). The glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) transcript was used as an internal control for RNA loading per lane.
(C) DNA (Southern) filter hybridization analysis of HBV replication
intermediates. HBV RC DNA, HBV relaxed circular DNA; HBV SS DNA,
HBV single-stranded DNA. (D) Quantitative analysis of the 3.5-kb HBV RNA
and HBV DNA replication intermediates. The levels of the 3.5-kb HBV RNA
and HBV DNA replication intermediates are reported relative to the HBV DNA
(4.1 kbp) XPC construct (lane 4) which are designated as having a relative
activity of 1.0. The mean RNA and DNA levels plus standard deviations from
two independent analyses are shown. The lower DNA/RNA ratios observed with
theϕ sequence mutant constructs that are statistically different by Student's t test
(p<0.05) from the DNA/RNA ratios observed with the constructs lacking ϕ
sequence mutants are indicated with asterisks (*).
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with the HBV DNA (4.1 kbp) XPC construct whereas 3.5-
kb RNA synthesis was essentially unaffected (Fig. 4). These
observations suggest that the M15 5′ε mutation reduces
encapsidation approximately two-fold as previously described
(Pollack and Ganem, 1993) and the introduction of the com-pensating mutation M15ϕ into the ϕ sequence restores both the
base pairing in the ε/ϕ structure and the replication efficiency of
the encapsidated pregenomic RNA (Fig. 4). However, the
possibility that the replication efficiency, in addition to the
encapsidation efficiency, is affected to some degree by the
sequence of the M15 mutations cannot be rigorously excluded.
Introduction of the same combinations of mutations into the
HBV DNA (4.1 kbp) XPC construct carrying the M15ε
mutation in the 3′ε sequence produced very similar results (Fig.
4). The M15 3′ε mutation did not affect HBV RNA or DNA
synthesis (Fig. 4). The M15 5′ε3′ε and M15 ϕ3′ε double
mutations did not affect pregenomic RNA synthesis, but the
level of viral replication per 3.5-kb viral transcript was reduced
approximately three-fold. When the M15 5′εϕ3′ε mutations
were combined, the level of viral replication per 3.5-kb viral
transcript was approximately twice the level observed with the
M15 5′ε3′ε and M15 ϕ3′ε double mutations, again supporting
the contention that the M15 5′ε and the M15ϕ mutations
compensate for each other functionally (Fig. 4). These
observations support the suggestion that the ε/ϕ structure is
an important intermediate in the initial steps of HBV minus-
strand DNA synthesis.
The M14ϕ mutation reduced replication to a rather modest
extent without affecting pregenomic RNA synthesis (Figs. 3
and 5). Despite the limited effect of the M14ϕ mutation, the
effect of introducing the corresponding compensatory muta-
tions into ε was examined (Fig. 5). The compensatory mutation,
M14ε (Figs. 1 and 5), introduced into the upper stem of ε has
been characterized previously and shown to support encapsida-
tion of pregenomic RNA at a level similar to the wild-type RNA
(Pollack and Ganem, 1993). Consequently, it was assumed that
the M14ε mutation would support viral replication. However,
the M14ε mutation introduced into the ε sequence at the 5′-end
of the pregenomic RNA (M14 5′ε) completely failed to support
viral replication despite having no affect on pregenomic RNA
synthesis (Fig. 5). The level of replication supported by theFig. 3. Effect of additionalmutations in theϕ sequence onHBV transcription and
replication in HepG2 cells. (A) Structure of the putative HBV ε/ϕ stem–bulge
sequence (Tang and McLachlan, 2002a). The location of the HBV polymerase
with the three covalently attached nucleotides after translocation from ε to DR1 is
indicated. The locations of the M14ϕ to M17ϕmutations are also indicated. The
pregenomic RNA sequence is derived from the HBVayw genome (Galibert et al.,
1979). (B) RNA (Northern) filter hybridization analysis of HBV transcripts. Cells
were transiently transfected with the wild-type HBV DNA (4.1 kbp) construct
(lane 1) and the mutant HBV DNA (4.1 kbp) constructs X (lane 2), PC (lane
3), XPC (lane 4), M14ϕ (lane 5), M15ϕ (lane 6), M16ϕ (lane 7) and
M17ϕ (lane 8). The glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
transcript was used as an internal control for RNA loading per lane. (C) DNA
(Southern) filter hybridization analysis of HBV replication intermediates. HBV
RC DNA, HBV relaxed circular DNA; HBV SS DNA, HBV single-stranded
DNA. (D) Quantitative analysis of the 3.5-kb HBV RNA and HBV DNA
replication intermediates. The levels of the 3.5-kb HBV RNA and HBV DNA
replication intermediates are reported relative to the HBV DNA (4.1 kbp)
XPC construct (lane 4) which are designated as having a relative activity of
1.0. The mean RNA and DNA levels plus standard deviations from two
independent analyses are shown. The lower DNA/RNA ratios observed with the
ϕ sequence mutant constructs that are statistically different by Student's t test
(p<0.05) from the DNA/RNA ratios observed with the constructs lacking ϕ
sequence mutants are indicated with asterisks (*).
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mutation it failed to support any viral DNA synthesis (Fig. 5).
These results indicate that certain mutations in ε may support
encapsidation under certain circumstances but fail to support the
complete viral replication cycle. This suggests that there may be
sequence specific requirements for the ε sequence which are
necessary for viral DNA synthesis but not for encapsidation.
Alternatively, the M14 5′ε mutation may simply fail to support
encapsidation under the current conditions. In addition, these
observations indicate how difficult it can be to generate
functional ε mutations which might be used to test the
hypothetical base pairing between the 5′-half of the ε sequence
and the ϕ sequence for their roles in the initiation of minus-
strand DNA synthesis (Tang and McLachlan, 2002a).
The ϕ sequence is not functionally equivalent to the ε sequence
for HBV replication
From these studies, it is apparent that it is not trivial to find
mutations in the ε sequence which can support pregenomic
RNA encapsidation and viral replication. However, it is
apparent that mutations can be introduced into the 3′-half of ε
to convert this sequence to the ϕ sequence without altering the
coding potential of the HBV DNA (4.1 kbp) XPC construct
(Figs. 1 and 6). Creating an HBV genome where the 3′-half of ε
is converted to the ϕ sequence permits the potential functional
properties of the putative ε/ϕ base pairing to be examined.
Introduction of the ϕ sequence into the ε sequence at the 5′-end
of the pregenomic RNA does not affect viral transcription but
fails to support any viral replication. This indicates that the ε/ϕ
base paired structure, if formed, is not functionally equivalent toFig. 4. Effect of compensatory mutations in the ε and ϕ sequences on HBV
transcription and replication in HepG2 cells. (A) Structure of the HBV ε stem/
loop sequence (Junker-Niepmann et al., 1990). The location of the HBV
polymerase with the three covalently attached nucleotides prior to translocation
from ε to DR1 is indicated. The location of the M15ε mutation is also indicated.
The pregenomic RNA sequence is derived from the HBVayw genome (Galibert
et al., 1979). (B) Structure of the putative HBV ε/ϕ stem–bulge sequence (Tang
and McLachlan, 2002a). The location of the HBV polymerase with the three
covalently attached nucleotides after translocation from ε to DR1 is indicated.
The location of the M15ε and M15ϕ mutations is also indicated. The
pregenomic RNA sequence is derived from the HBVayw genome (Galibert et
al., 1979). (C) RNA (Northern) filter hybridization analysis of HBV transcripts.
Cells were transiently transfected with the wild-type HBV DNA (4.1 kbp)
construct (lane 1) and the mutant HBV DNA (4.1 kbp) constructs X (lane 2),
PC (lane 3), XPC (lane 4), M15 ϕ (lane 5), M15 5′ε (lane 6), M15 5′εϕ
(lane 7), M15 3′ε (lane 8), M15 ϕ3′ε (lane 9), M15 5′ε3′ε (lane 10) and M15
5′εϕ3′ε (lane 11). The glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
transcript was used as an internal control for RNA loading per lane. (D) DNA
(Southern) filter hybridization analysis of HBV replication intermediates.
HBV RC DNA, HBV relaxed circular DNA; HBV SS DNA, HBV single-
stranded DNA. (E) Quantitative analysis of the 3.5-kb HBV RNA and HBV
DNA replication intermediates. The levels of the 3.5-kb HBV RNA and HBV
DNA replication intermediates are reported relative to the HBV DNA (4.1 kbp)
XPC construct (lane 4) which are designated as having a relative activity of
1.0. The mean RNA and DNA levels plus standard deviations from three
independent analyses are shown. The lower DNA/RNA ratios observed with the
ε and ϕ sequence mutant constructs that are statistically different by Student's t
test (p<0.05) from the DNA/RNA ratios observed with the constructs lacking ε
and ϕ sequence mutants are indicated with asterisks (*).
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this putative structure is introduced into the 5′-end of the
pregenomic RNA at the same location as the ε sequence.
Therefore, this analysis is unable to determine if the ε/ϕ
structure can be bound by the HBV polymerase as predicted by
the proposed role of the ϕ sequence in the early steps of viral
replication. This may reflect the inability of polymerase to
recognize the ε/ϕ structure until the initial three nucleotides of
minus-strand DNA are synthesized. The observation that the ε
to ϕ mutation can be introduced into the ε sequence at the
3′-end of the pregenomic RNA (Mεtoϕ 3′ε) indicates that this
mutation does not have a dominant negative effect on viral
replication (Fig. 6).Discussion
In our previous studies, the ϕ sequence was identified as a 19
nucleotide regulatory element located 32 nucleotides upstream
of the DR1 element at the 3′-end of the HBV 3.5-kb pregenomic
RNA (Tang and McLachlan, 2002a). This element did not affect
the level of pregenomic RNA synthesis but was necessary for
efficient viral DNA synthesis (Tang and McLachlan, 2002a). In
addition, the ϕ sequence was complementary to the 5′-half of
the ε sequence and phylogenetically conserved between the
woodchuck and human hepatitis B viruses (Tang and McLa-
chlan, 2002a). These observations led to the suggestion that the
role of the ϕ sequence in viral replication is probably at an early
step in the replication cycle and is most likely involved in the
process of the translocation of the HBV polymerase from ε at
the 5′-end of the pregenomic RNA to the DR1 sequence at the
3′-end of the pregenomic RNA (Tang and McLachlan, 2002a).
The basic model involves the HBV polymerase recognizing and
binding to ε. Inside the immature capsid, the polymerase uses
the bulge region of ε as a template and the tyrosine residue in the
terminal-protein domain of the polymerase as a primer to
synthesize the first three nucleotides of the HBV minus-strand
DNA. During or subsequent to this synthesis, the polymerase
and/or ε undergoes a conformational change resulting in the
displacement of the 3′-half of ε and its replacement with the ϕ
sequence generating a polymerase plus ε/ϕ complex with a
similar structure to the polymerase plus ε structure except the
loop in the RNA stem/loop structure is now approximately 3-kb
rather than six nucleotides as found in the ε structure (Tang and
McLachlan, 2002a). This strand displacement reaction gener-
ates a complex where the original three nucleotides reverse
transcribed from the loop of ε are now in close proximity to their
target sequence at the 5′-end of the DR1 sequence (Tang and
McLachlan, 2002a). Presumable the close proximity of this tri-
nucleotide priming sequence to DR1 promotes their interaction
and the initiation of the extension reaction necessary for
complete minus-strand synthesis using the pregenomic RNA as
a template. The subsequent synthesis of the plus-strand HBV
DNA would complete the production of the viral genome and
generate the mature capsid found in the virus particles (Ganem
and Schneider, 2001; Raney and McLachlan, 1991).Fig. 5. Effect of additional mutations in the ε and ϕ sequences on HBV
transcription and replication in HepG2 cells. (A) Structure of the HBV ε stem/
loop sequence (Junker-Niepmann et al., 1990). The location of the HBV
polymerase with the three covalently attached nucleotides prior to translocation
from ε to DR1 is indicated. The location of the M14ε mutation is also indicated.
The pregenomic RNA sequence is derived from the HBVayw genome (Galibert
et al., 1979). (B) Structure of the putative HBV ε/ϕ stem–bulge sequence (Tang
and McLachlan, 2002a). The location of the HBV polymerase with the three
covalently attached nucleotides after translocation from ε to DR1 is indicated.
The location of theM14ε andM14ϕmutations is also indicated. The pregenomic
RNA sequence is derived from the HBVayw genome (Galibert et al., 1979). (C)
RNA (Northern) filter hybridization analysis of HBV transcripts. Cells were
transiently transfected with the mutant HBV DNA (4.1 kbp) constructs XPC
(lane 1), M14 ϕ (lane 2), M14 5′ε (lane 3) and M14 5′εϕ (lane 4). The
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) transcript was used as an
internal control for RNA loading per lane. (D) DNA (Southern) filter
hybridization analysis of HBV replication intermediates. HBV RC DNA, HBV
relaxed circular DNA; HBV SS DNA, HBV single-stranded DNA.
378 C.E. Oropeza, A. McLachlan / Virology 359 (2007) 371–381Based on this model for the role of the ϕ sequence in the
initiation of minus-strand DNA synthesis, it is predicted that for
the ϕ sequence to facilitate HBV replication it must be able to
base pair with the 5′-half of the ε sequence. To functionally
examine this possibility, it is necessary to identify mutations in
theϕ sequence that reduce viral replication efficiency and can be
compensated for by the complementary mutations in the ε
sequence. Although this is straightforward in principle, it is an
extremely difficult challenge to identify the appropriate muta-
tions given the functional importance of both the ε sequence and
structure to its role in polymerase recognition and the initiationof minus-strand DNA synthesis (Pollack and Ganem, 1993; Hu
and Boyer, 2006).
In an initial attempt to address this issue, a comprehensive
mutational analysis of the ϕ sequence was performed to deter-
mine in detail the region of this element that was most important
for viral replication (Figs. 2 and 3). Based on mutations M11ϕ,
M12ϕ and M15ϕ, it appears that the 5′-half of the ϕ sequence
which is proposed to form the upper stem structure with the
5′-half of the ε sequence is the most important functional region
of the ϕ sequence. Based on mutations M13ϕ, M16ϕ and
M17ϕ, it appears that the 3′-half of the ϕ sequence which is
proposed to form the lower stem structure with the 5′-half of the
ε sequence is a less important functional region of the ϕ
sequence. However, this mutational analysis supports the
suggestion that the wholeϕ sequence contributes to the function
of this element in governing the efficiency of viral replication. In
addition, the M10ϕ mutation suggests that up to six additional
nucleotides located directly upstream of the ϕ sequence may
also contribute to the efficiency of viral replication (Fig. 2).
Previous analysis had also suggested that this region upstream of
the ϕ sequence might contribute to the efficiency of viral
replication (Tang and McLachlan, 2002a).
The mutagenesis analysis of the ϕ sequence suggested that
the 5′-end of theϕ sequence might be a suitable target region for
designing mutations which might be compensated for by
introducing the complementary mutations into the ε sequence.
Based on previous studies (Pollack and Ganem, 1993), it
appeared that the complementary mutation toM15ϕwithin the ε
sequence, M15ε, should support encapsidation of pregenomic
RNA. Indeed, the M15ε and the M15ϕ mutations were able to
support viral replication although at a significantly reduced level
per 3.5-kb viral transcript compared with the HBVDNA (4.1 kb)
XPC construct (Fig. 4). When both the M15ε and the M15ϕ
mutations were introduced into the pregenomic RNA, the level
of replication per 3.5-kb viral transcript was increased to
approximately half the level observed with the HBV DNA
(4.1 kb) XPC construct (Fig. 4). This modest reduction in
replication efficiency may be attributed to the reduced encap-
sidation efficiency of the M15ε mutation (Pollack and Ganem,
1993) or, alternatively, may reflect slightly reduced replicationFig. 6. Effect of mutating the 3′-half of the ε sequence to the ϕ sequence on
HBV transcription and replication in HepG2 cells. (A) Structure of the HBV ε
stem/loop sequence (Junker-Niepmann et al., 1990). The location of the HBV
polymerase with the three covalently attached nucleotides prior to translocation
from ε to DR1 is indicated. The location of the Mεtoϕmutation is also indicated.
The pregenomic RNA sequence is derived from the HBVayw genome (Galibert
et al., 1979). (B) Putative structure of the HBV ε/ϕ stem/loop sequence
produced by the Mεtoϕ mutation. The presumed location of the HBV
polymerase with the three covalently attached nucleotides prior to translocation
from putative mutant HBV ε/ϕ stem/loop structure to DR1 is indicated. The
pregenomic RNA sequence is derived from the HBVayw genome (Galibert et
al., 1979). (C) RNA (Northern) filter hybridization analysis of HBV transcripts.
Cells were transiently transfected with the mutant HBV DNA (4.1 kbp)
constructs, XPC (lane 1), Mεtoϕ 5′ε (lane 2), Mεtoϕ 3′ε (lane 3) and Mεtoϕ
5′ε3′ε (lane 4). The glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
transcript was used as an internal control for RNA loading per lane. (D) DNA
(Southern) filter hybridization analysis of HBV replication intermediates. HBV
RC DNA, HBV relaxed circular DNA; HBV SS DNA, HBV single-stranded
DNA.
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thesis. In general, these findings support the suggestion that base
pairing between the 5′-half of the ε sequence and theϕ sequence
contributes to efficient viral replication, presumably during the
initial steps of minus-strand DNA synthesis.
In an attempt to find additional mutations in the ε sequence
that could compensate for mutations in theϕ sequence, the effect
of the M14ε mutation was examined (Fig. 5). This mutation
would permit base pairing with the corresponding M14ϕ muta-
tion in the ϕ sequence (Fig. 5) which we have demonstrated to
modestly influence the efficiency of viral replication (Fig. 4).
The M14εmutation has been shown previously to permit essen-
tially wild-type levels of encapsidation of pregenomic RNA
(Pollack andGanem, 1993) and therefore appeared to represent a
suitable candidate for this analysis. However, theM14εmutation
failed to support any viral replication and the compensating
M14ϕ mutation did not restore any HBV DNA synthesis (Fig.
5). This result suggests that the sequence in addition to the
structure of ε is important in determining viral replication and
illustrates the difficulty in identifying suitable mutations in ε for
analysis of compensating mutations in the ϕ sequence.
In an attempt to directly establish the functional significance
of the ε/ϕ structure for viral replication, the sequence of the
3′-half of εwas changed to theϕ sequence (Fig. 6). If this mutant
pregenomic RNA was capable of supporting any level of viral
replication, it would demonstrate that the HBV polymerase was
capable of functionally interacting with the ε/ϕ structure.
However, the Mεtoϕmutation did not support any viral replica-
tion (Fig. 6). This demonstrates that the ε/ϕ structure is not
functionally equivalent to the ε stem/loop structure. In addition,
these analyses indicate that the function of the ε stem/loop
structure and the putative ε/ϕ structure depend both on their
primary sequences as well as their secondary and potentially
tertiary structure. Recently, similar conclusions were reached by
others (Abraham and Loeb, 2006), supporting the suggestion
that base pairing between ε and ϕ sequence contributes to but
is not the only determinant governing the efficiency of viral
replication.
Materials and methods
Plasmid constructions
The steps in the cloning of the plasmid constructs used in the
transfection experiments were performed by standard techniques
(Sambrook et al., 1989). HBV DNA sequences in these con-
structions were derived from the plasmid pCP10, which contains
two copies of the HBV genome (subtype ayw) cloned into the
EcoRI site of pBR322 (Dubois et al., 1980). The HBV DNA
(4.1 kbp) construct that contains 1.3 copies of the HBV genome
includes the viral sequence from nucleotide coordinates 1072 to
3182 plus 1 to 1990. This plasmid was constructed by cloning
the NsiI/BglII HBV DNA fragment (nucleotide coordinates
1072 to 1990) into pUC13, generating pHBV (1072–1990).
Subsequently, a complete copy of the 3.2 kbp viral genome
linearized at the NcoI site (nucleotide coordinates 1375 to 3182
plus 1 to 1374) was cloned into the unique NcoI site (HBVnucleotide coordinate 1374) of pHBV (1072–1990), generating
the HBV DNA (4.1 kbp) construct (Fig. 1A).
The HBV DNA (4.1 kbp) X-, PC-, and XPC constructs
were derived by introducing the A1376G, A1816G and both
nucleotide substitutions, respectively, into the X-gene and the
precore coding regions in the HBV DNA (4.1 kbp) construct
using the QuickChange II site-directed mutagenesis kit
(Stratagene Cloning Systems, La Jolla, CA) according to
the manufacturer's instructions. The A1376G and A1816G
nucleotide substitutions converted the X-gene and precore
translation initiation codons from ATG to GTG, preventing
the initiation of translation of the X-gene and precore
polypeptides, respectively. The nucleotide substitutions intro-
duced into the X-gene and precore initiation codons were
verified by dideoxynucleotide sequencing (Sanger et al.,
1977). The X-gene and precore initiation codons at both the
5′- and 3′-ends of these terminally redundant HBV constructs
were mutated for this analysis.
The plasmids, M9ϕ, M10ϕ, M11ϕ, M12ϕ, M13ϕ, M14ϕ,
M15ϕ, M16ϕ and M17ϕ, were derived by introducing the
nucleotide substitutions indicated in Fig. 1 into the ϕ region
between coordinates 1763 and 1792 located immediately
upstream of the 3′ DR1 element in the HBV DNA (4.1 kbp)
XPC construct. The plasmids, M14ε, M15ε and Mεtoϕ,
were derived by introducing the nucleotide substitutions
indicated in Fig. 1 into the ε sequence between coordinates
1869 and 1902 located at either or both the 5′- and 3′-ends of
the HBV DNA (4.1 kbp) XPC construct. The QuickChange
II site-directed mutagenesis kit (Stratagene Cloning Systems, La
Jolla, CA) was used according to the manufacturer's instruc-
tions to generate these mutated HBV DNA (4.1 kbp) XPC
constructs. The nucleotide substitutions introduced into the ε
and ϕ regions of these constructs were verified by dideox-
ynucleotide sequencing (Sanger et al., 1977).
Cells and transfections
The human hepatoma cell line HepG2 was grown in RPMI-
1640 medium and 10% fetal bovine serum at 37 °C in 5% CO2/
air. Transfections for viral RNA and DNA analysis were
performed as previously described (McLachlan et al., 1987)
using 10 cm plates, containing approximately 1×106 cells.
Cells were transfected with 15 μg of HBV DNA (4.1 kbp)
constructs, and DNA and RNA isolation was performed 3 days
post transfection (Tang and McLachlan, 2001).
Characterization of HBV transcripts and viral replication
intermediates
Transfected cells from a single plate were divided equally and
used for the preparation of total cellular RNA and viral DNA
replication intermediates as described previously (Summers et
al., 1991) with minor modifications (Tang and McLachlan,
2001). For RNA isolation (Chomczynski and Sacchi, 1987), the
cells were lysed in 1.8 ml of 25 mM sodium citrate, pH 7.0, 4 M
guanidinium isothiocyanate, 0.5% (v/v) sarcosyl and 0.1 M
2-mercaptoethanol. After addition of 0.18 ml of 2 M sodium
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saturated phenol plus 0.36 ml of chloroform–isoamyl alcohol
(49:1). After centrifugation for 30 min at 3000 rpm in a Sorval
RT6000, the aqueous layer was precipitated with 1.8 ml of
isopropanol. The precipitate was resuspended in 0.3 ml of
25 mM sodium citrate, pH 7.0, 4 M guanidinium isothiocyanate,
0.5% (v/v) sarcosyl and 0.1 M 2-mercaptoethanol and preci-
pitated with 0.6 ml of ethanol. After centrifugation for 20 min at
14,000 rpm in an Eppendorf 5417C microcentifuge, the
precipitate was resuspended in 0.3 ml of 10 mM Tris hydro-
chloride, pH 8.0, 5 mM EDTA and 0.1% (w/v) sodium lauryl
sulfate and precipitated with 45 μl of 2 M sodium acetate plus
0.7 ml of ethanol.
For the isolation of viral DNA replication intermediates, the
cells were lysed in 0.4 ml of 100mMTris hydrochloride, pH 8.0,
0.2% (v/v) NP40. The lysate was centrifuged for 1 min at
14,000 rpm in an Eppendorf 5417Cmicrocentrifuge to pellet the
nuclei. The supernatant was adjusted to 6.75 mM magnesium
acetate plus 200 μg/ml DNase I and incubated for 1 h at 37 °C to
remove the transfected plasmid DNA. The supernatant was
readjusted to 100 mM NaCl, 10 mM EDTA, 0.8% (w/v) sodium
lauryl sulfate and 1.6 mg/ml pronase and incubated for an
additional 1 h at 37 °C. The supernatant was extracted twice with
phenol, precipitated with two volumes of ethanol and resus-
pended in 100 μl of 10 mM Tris hydrochloride, pH 8.0, 1 mM
EDTA.
RNA (Northern) and DNA (Southern) filter hybridization
analysis was performed using 10 μg of total cellular RNA
and 30 μl of viral DNA replication intermediates, respec-
tively, as described (Sambrook et al., 1989). Filter hybrid-
ization analyses were quantitated by phosphorimaging using
a Molecular Dynamics Storm 860 phosphoimager.
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